Quality Assurance Evolution in the Biopharmaceutical CDMO Industry – stricter regulations, technological advancements, risk management, globalisation and client expe...

Pharma companies remain at differing levels of readiness for implementing ISO IDMP product data standards, and in their maturity around adopting FAIR data principles...

Viral vector-based therapeutics have revolutionised modern medicine, enabling precise gene delivery for treating genetic disorders, cancers, and infectious diseases....

The emergence of RNA vaccines against SARS-CoV-2 has revolutionised the biomedical field, offering unprecedented flexibility, precision, and scalability in therapeut...

“What we believe in, is putting the best biology we can into our models to mimic human biology”. In recent years, there have been significant advances in technolo...

When determining a test for pyrogens and bacterial endotoxin, there are many regulations, needs, limitations, and techniques to consider. The original pyrogen test, ...

The pharmaceutical industry is undergoing a trans- formative period, driven by advancements in technology, evolving patient needs, and the increasing demand for high...

In the modern pharmaceutical industry, Contract Development and Manufacturing Organisations (CDMOs) have become integral players. However, this was not always the ca...

The healthcare industry’s demand for safe, effective, and accessible advanced therapeutics is rising rapidly. Drug developers are becoming more competitive in the ra...